Final NHS nod for Roche’s RoActemra

19th April 2018 Uncategorised 0

Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators.

More: Final NHS nod for Roche’s RoActemra
Source: News